WASHINGTON: The White House said the ethical issues associated with gene-editing on the human genome need further study by the scientific community and should not be pursued until issues are resolved.
"The administration believes that altering the human germline for clinical purposes is a line that should not be crossed at this time," John Holdren, director of the White House Office of Science and Technology Policy, said in a statement.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
